Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
By Michael Erman NEW YORK, Dec 31 (Reuters) – Drugmakers plan to raise U.S. prices on at least…
Generics of Ozempic and Wegovy expected to lower insurance costs for employers and workers
Open this photo in gallery: Ozempic and Wegovy will lose market exclusivity in Canada in January, paving the…
Is tramadol really ineffective and risky?
For nearly half a century, tramadol has been used as a pain reliever. It is not perfect, no…
Sodium bicarbonate and rosemary for grey hair : purpose and usage explained
Gray hair represents one of the most visible markers of aging, prompting countless individuals to seek solutions that…
Flu is rising rapidly, driven by a new variant. Here’s what to know
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
India bans high-dose nimesulide: Health risks behind the decision
The government has banned nimesulide in doses above 100 mg, citing health risks linked to its use in…
Andhra allowing Ayurveda doctors to perform surgery puts patients at risk: PV Ramesh
A week ago, the Andhra Pradesh Health, Medical Education and Family Welfare ministry allowed Ayurvedic doctors to perform…
GLP-1 psychological side effects: a psychiatrist’s view
As a physician-psychiatrist, I have watched the rise of GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) with genuine admiration.…
Doctors are concerned over ivermectin’s renewed popularity : NPR
Ivermectin’s reputation keeps growing as a kind of cure-all, even for cancer — despite evidence it doesn’t work.…
Welder’s Anthrax Treated with Obiltoxaximab — Louisiana, 2024
Investigation and Findings Identification of Patient On September 7, 2024, CDC and the Louisiana Department of Health (LDH)…
Nimesulide banned: Govt puts a stop to manufacture, sale of all oral formulations containing the popular painkiller above 100 mg
The Union Health Ministry has banned the manufacture, sale and distribution of all oral formulations containing the popular…
Stock and Share Market News, Economy and Finance News, Sensex, Nifty, Global Market, NSE, BSE Live IPO News
Motilal Oswal Nifty Microcap 250 Index Fund – Direct Plan – Growth Today’s value of ₹1000 SIP 3…